InsiderClue
Insiders · Profile

Priebe Waldemar

10% owner at CNS Pharmaceuticals · 10% owner at Moleculin Biotech. Filing since 16 Aug 2017. CIK 0001678516

CNSP CNS Pharmaceuticals, Inc. 10% owner · 17 trades MBRX Moleculin Biotech, Inc. 10% owner · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
CNSP CNS Pharmaceuticals, Inc.
28 Mar 2023
10% owner
Sold on a plan
10,000
$10.40K
6.0%
CNSP CNS Pharmaceuticals, Inc.
27 Mar 2023
10% owner
Sold on a plan
5,000
$5.45K
2.9%
CNSP CNS Pharmaceuticals, Inc.
24 Mar 2023
10% owner
Sold on a plan
5,000
$5.40K
2.8%
CNSP CNS Pharmaceuticals, Inc.
23 Mar 2023
10% owner
Sold on a plan
10,000
$10.80K
5.4%
CNSP CNS Pharmaceuticals, Inc.
22 Mar 2023
10% owner
Sold on a plan
5,000
$5.40K
2.6%
CNSP CNS Pharmaceuticals, Inc.
21 Mar 2023
10% owner
Sold on a plan
5,000
$5.50K
2.5%
CNSP CNS Pharmaceuticals, Inc.
20 Mar 2023
10% owner
Sold on a plan
5,000
$5.40K
2.5%
CNSP CNS Pharmaceuticals, Inc.
17 Mar 2023
10% owner
Sold on a plan
5,000
$5.65K
2.4%
CNSP CNS Pharmaceuticals, Inc.
16 Mar 2023
10% owner
Sold on a plan
5,000
$6.20K
2.4%
CNSP CNS Pharmaceuticals, Inc.
15 Mar 2023
10% owner
Sold on a plan
5,000
$6.10K
2.3%
CNSP CNS Pharmaceuticals, Inc.
14 Mar 2023
10% owner
Sold on a plan
5,000
$6.75K
2.3%
CNSP CNS Pharmaceuticals, Inc.
13 Mar 2023
10% owner
Sold on a plan
5,000
$6.50K
2.2%
CNSP CNS Pharmaceuticals, Inc.
10 Mar 2023
10% owner
Sold on a plan
5,000
$6.45K
2.2%
CNSP CNS Pharmaceuticals, Inc.
9 Dec 2022
10% owner
Sold on a plan
2,798
$6.80K
1.2%
CNSP CNS Pharmaceuticals, Inc.
8 Dec 2022
10% owner
Sold on a plan
5,500
$13.20K
2.3%
CNSP CNS Pharmaceuticals, Inc.
7 Dec 2022
10% owner
Sold on a plan
5,500
$13.53K
2.2%
CNSP CNS Pharmaceuticals, Inc.
6 Dec 2022
10% owner
Sold on a plan
5,500
$13.59K
2.2%
MBRX Moleculin Biotech, Inc.
16 Aug 2017
10% owner
Sold, plan not stated
100,000
$170.30K
3.5%
18 decisions on file.